Discounts For Drugs Not Covered By Insurance

Sprintec Coupon

Lowest discount price for: Sprintec 0.25-0.035 TABLET at WALMART PHARMACY See More Pricing

Save 27% on Your Prescription

Average Retail:$23.21

Coupon Price:$16.92

Sprintec Prescription Drug Coupon

You can show the pharmacist this coupon from your phone.

Print this free Sprintec Coupon to get the lowest price on your prescription medication. This discount drug coupon is pre-activated and can be used immediately to save up to 75% at your pharmacy. This coupon is accepted at over 68,000 pharmacies nationwide, including: Walgreens, CVS Pharmacy, Walmart Pharmacy, Rite Aid, Kroger, Kmart Pharmacy, and Safeway.

Coupon Instructions

STEP 1: Print your coupon, it's pre-activated.

STEP 2: Bring to your local pharmacy.

STEP 3: Save on your prescription costs!

Sprintec 0.25-0.035 TABLET

Drug Information: Sprintec

Indications and Usage

Sprintec® (norgestimate and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy.

Dosing and Administration

Sprintec is dispensed in a blister pack tablet dispenser. Sprintec may be started using either a Day 1 start or a Sunday start. For the first cycle of a Sunday Start regimen, an additional method of contraception should be used until after the first 7 consecutive days of administration.

Dosage Forms and Strengths

  • 0.250 mg norgestimate and 0.035 mg ethinyl estradiol tablet

Contraindications

Do not prescribe Sprintec to women who are known to have the following conditions:

  • A high risk of arterial or venous thrombotic diseases
  • Smoke, if over age 35
  • Have deep vein thrombosis or pulmonary embolism, now or in the past
  • Have inherited or acquired hypercoagulopathies
  • Have cerebrovascular disease
  • Have coronary artery disease
  • Have thrombogenic valvular or thrombogenic rhythm diseases of the heart
  • Have uncontrolled hypertension
  • Have diabetes mellitus with vascular disease

Warnings and Precautions

Stop Sprintec if an arterial thrombotic event or venous thromboembolic (VTE) event occurs.

Stop Sprintec if there is unexplained loss of vision, proptosis, diplopia, papilledema, or retinal vascular lesions. Evaluate for retinal vein thrombosis immediately

Do not use Sprintec in women with liver disease, such as acute viral hepatitis or severe (decompensated) cirrhosis of liver. Acute or chronic disturbances of liver function may necessitate the discontinuation of COC use until markers of liver function return to normal and COC causation has been excluded. Discontinue Sprintec if jaundice develops.

Studies suggest a small increased relative risk of developing gallbladder disease among COC users. Use of COCs may worsen existing gallbladder disease. A past history of COC-related cholestasis predicts an increased risk with subsequent COC use. Women with a history of pregnancy-related cholestasis may be at an increased risk for COC related cholestasis.

If a woman taking Sprintec develops new headaches that are recurrent, persistent, or severe, evaluate the cause and discontinue Sprintec if indicated.

Carefully observe women with a history of depression and discontinue Sprintec if depression recurs to a serious degree.

Chloasma may occasionally occur, especially in women with a history of chloasma gravidarum. Women with a tendency to chloasma should avoid exposure to the sun or ultraviolet radiation while taking Sprintec.

The estrogen component of COCs may raise the serum concentrations of thyroxine-binding globulin, sex hormone-binding globulin, and cortisol-binding globulin. The dose of replacement thyroid hormone or cortisol therapy may need to be increased.

Adverse Reactions

Infections and Infestations: Urinary tract infectio

Neoplasms Benign, Malignant and Unspecified (Incl. Cysts and Polyps): Breast cancer, benign breast neoplasm, hepatic adenoma, focal nodular hyperplasia, breast cyst

Immune System Disorders: Hypersensitivity

Metabolism and Nutrition Disorders: Dyslipidemia

Psychiatric Disorders: Anxiety, insomnia

Nervous System Disorders: Syncope, convulsion, paresthesia, dizziness

Eye Disorders: Visual impairment, dry eye, contact lens intolerance

Ear and Labyrinth Disorders: Vertigo

Cardiac Disorders: Tachycardia, palpitations

Vascular Events: Deep vein thrombosis, pulmonary embolism, retinal vascular thrombosis, hot flush

Respiratory, Thoracic and Mediastinal Disorders: Dyspnea

Hepatobiliary Disorders: Hepatitis

Skin and Subcutaneous Tissue Disorders: Angioedema, erythema nodosum, hirsutism, night sweats, hyperhidrosis, photosensitivity reaction, urticaria, pruritus, acne

Musculoskeletal, Connective Tissue, and Bone Disorders: Muscle spasms, pain in extremity, myalgia, back pain

Drug Interactions

Drugs or herbal products that induce certain enzymes, including cytochrome P450 3A4 (CYP3A4), may decrease the plasma concentrations of COCs and potentially diminish the effectiveness of COCs or increase breakthrough bleeding. Some drugs or herbal products that may decrease the effectiveness of hormonal contraceptives include phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampicin, topiramate, rifabutin, rufinamide, aprepitant, and products containing St. John’s wort. Interactions between hormonal contraceptives and other drugs may lead to breakthrough bleeding and/or contraceptive failure. Counsel women to use an alternative method of contraception or a back-up method when enzyme inducers are used with COCs, and to continue back-up contraception for 28 days after discontinuing the enzyme inducer to ensure contraceptive reliability.

Colesevelam, a bile acid sequestrant, given together with a COC, has been shown to significantly decrease the AUC of EE. The drug interaction between the contraceptive and colesevelam was decreased when the two drug products were given 4 hours apart.

Co-administration of atorvastatin or rosuvastatin and certain COCs containing ethinyl estradiol (EE) increase AUC values for EE by approximately 20 to 25%. Ascorbic acid and acetaminophen may increase plasma EE concentrations, possibly by inhibition of conjugation. CYP3A4 inhibitors such as itraconazole, voriconazole, fluconazole, grapefruit juice, or ketoconazole may increase plasma hormone concentrations.

This is not a medicare prescription drug plan. Program is privately supported.
This is not a government run/affiliated/funded program.
Discounts are only available at participating pharmacies.
This program/card is a drug coupon. THIS IS NOT INSURANCE. More Info

2018 © NonCoveredDrugs.com